News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Evolutec Ltd Gets Positive Pre-clinical Data On Lead Molecule
February 28, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Evolutec Group PLC said it got a positive metabolic result from laboratory work on its lead molecule, rEV131, which the company is trying to develop into treatments for illnesses such as hayfever and asthma.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
PARTNERED WITH VIVA BIOTECH
Building the Next Generation of Biologics: Inside the Future of Protein Engineering
December 1, 2025
·
9 min read
·
BioSpace Insights
FDA
Are Animals Out? How NAMs Are Changing the Rules of the Game
November 26, 2025
·
7 min read
·
BioSpace Insights
Obesity
Novo Bounces Back With ‘Competitive’ Mid-Stage Weight Loss Data for Amycretin
November 25, 2025
·
2 min read
·
Tristan Manalac
Cancer
ASH25: Late-Stage Data For J&J’s Tecvayli/Darzalex Combo Could ‘Shift Paradigm’ in Myeloma
November 25, 2025
·
2 min read
·
Tristan Manalac
